{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:23:48Z","timestamp":1791242628053,"version":"4.1.0"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Interferon(IFN) system is dysregulated in Systemic Lupus Erythematosus(SLE) and represents potential therapeutic target. However, most studies have focused on isolated IFN types, particularly type I and type II, while type III IFNs remain poorly characterized. Comprehensive analysis of different IFN types in parallel with interferon-stimulated gene(ISG) expression is limited despite the interconnectedness of IFN families and their potential to differentially influence disease activity, immune phenotypes, and treatment responses. The present study assessed levels of IFN types and IFN score to evaluate their association with disease activity, clinical manifestations, and autoantibody profile in SLE patients from Western India.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This cross-sectional study included clinically diagnosed SLE patients(n=115). Serum IFN\u03b1 and IFN\u03bb1-\u03bb4 levels were detected using ELISA, while IFN\u03b3 levels were detected using bead-based assay, and IFN score by RT-qPCR based on the expression of five ISGs. SLE patients with IFN levels above third quartile were categorized as \u2018IFN high\u2019 groups, and their association with clinical and autoantibody profile were analysed using logistic regression. To identify patient subgroups based on autoantibody profile, unsupervised clustering was employed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>SLE patients showed significantly elevated IFN\u03b1(p&amp;lt;0.001), IFN\u03b3(p=0.009), and IFN\u03bb3(p&amp;lt;0.001) levels as well as IFN score(p&amp;lt;0.001) as compared to healthy controls. IFN score(r=0.228;p=0.014) and IFN\u03b1 levels(r=0.430;p&amp;lt;0.001) correlated positively with disease activity. IFN\u03b1 high group was associated with leukopenia (OR(95%CI):5.81(1.29,26.20);p=0.022) and multiple autoantibodies, while IFN\u03b3 high group with rash (OR(95%CI):2.73(1.06,7.00);p=0.037). FN\u03bb3 high group showed positive association with anti-Ro52 autoantibodies (OR(95%CI):2.64(1.07,6.52);p=0.035) and negative association with low complement (OR(95%CI):0.35(0.13,0.89);p=0.028). IFN\u03bb4 levels were not significantly elevated in SLE patients(p=0.642), however the levels were significantly associated with IFN score(r=0.359,p&amp;lt;0.001) and anti-dsDNA positivity(r=0.323,p&amp;lt;0.001), with higher levels observed in IFN score high SLE patients(p=0.016). Autoantibody profile-based clustering identified three subgroups differing in IFN\u03b1 levels, IFN scores, disease activity, and associated immunological parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>All three IFN pathways were elevated in SLE. Correlation of IFN\u03b1 levels and IFN score with SLEDAI suggested their potential as possible biomarker for monitoring disease activity. Association of IFN\u03bb4 with IFN score suggested their possible role in IFN pathway activation.By assessing IFNs at both protein and transcriptional levels, present study provided comprehensive insight into IFN pathway dynamics and IFN-driven heterogeneity in SLE.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1757895","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T06:41:22Z","timestamp":1769668882000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Interferon levels and interferon-stimulated gene expression identify patient subsets with distinct clinical and immunological characteristics in systemic lupus erythematosus"],"prefix":"10.3389","volume":"17","author":[{"given":"Ridi","family":"Khatri","sequence":"first","affiliation":[{"name":"Department of Clinical and Experimental Immunology, ICMR-National Institute of Immunohaematology","place":["Mumbai, Maharashtra, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrutha","family":"Jose","sequence":"additional","affiliation":[{"name":"ICMR-National Institute of Immunohaematology","place":["Mumbai, Maharashtra, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Rajadhyaksha","sequence":"additional","affiliation":[{"name":"Department of Medicine, Seth Gordhandas Sunderdas (G.S.) Medical College and King Edward Memorial Hospital","place":["Mumbai, Maharashtra,, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalpana","family":"Mehta","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Topiwala National Medical College (T.N.M.C.) & Bai Yamunabai Laxman Nair Charitable (B.Y.L.N.Ch.) Hospital","place":["Mumbai, Maharashtra, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilesh","family":"Nolkha","sequence":"additional","affiliation":[{"name":"Department of Medicine and Rheumatology, Topiwala National Medical College (T.N.M.C.) & Bai Yamunabai Laxman Nair Charitable (B.Y.L.N.Ch.) Hospital","place":["Mumbai, Maharashtra, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Kini","sequence":"additional","affiliation":[{"name":"Department of Medicine and Rheumatology, Topiwala National Medical College (T.N.M.C.) & Bai Yamunabai Laxman Nair Charitable (B.Y.L.N.Ch.) Hospital","place":["Mumbai, Maharashtra, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milind","family":"Nadkar","sequence":"additional","affiliation":[{"name":"Department of Medicine, Seth Gordhandas Sunderdas (G.S.) Medical College and King Edward Memorial Hospital","place":["Mumbai, Maharashtra,, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Jaiswal","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Immunology, ICMR-National Institute of Immunohaematology","place":["Mumbai, Maharashtra, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratiksha","family":"Pawar","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Immunology, ICMR-National Institute of Immunohaematology","place":["Mumbai, Maharashtra, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swapnal","family":"Pawaskar","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Immunology, ICMR-National Institute of Immunohaematology","place":["Mumbai, Maharashtra, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavyasree","family":"S","sequence":"additional","affiliation":[{"name":"Department of Medicine and Rheumatology, Topiwala National Medical College (T.N.M.C.) & Bai Yamunabai Laxman Nair Charitable (B.Y.L.N.Ch.) Hospital","place":["Mumbai, Maharashtra, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajit Kumar","family":"Das","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Topiwala National Medical College (T.N.M.C.) & Bai Yamunabai Laxman Nair Charitable (B.Y.L.N.Ch.) Hospital","place":["Mumbai, Maharashtra, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Durga","family":"Chougule","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Immunology, ICMR-National Institute of Immunohaematology","place":["Mumbai, Maharashtra, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirti","family":"Rai","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Immunology, ICMR-National Institute of Immunohaematology","place":["Mumbai, Maharashtra, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshada","family":"Konkar","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Immunology, ICMR-National Institute of Immunohaematology","place":["Mumbai, Maharashtra, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Korgaonkar","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Immunology, ICMR-National Institute of Immunohaematology","place":["Mumbai, Maharashtra, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smruti","family":"Patil","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Immunology, ICMR-National Institute of Immunohaematology","place":["Mumbai, Maharashtra, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prathamesh","family":"Warang","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Immunology, ICMR-National Institute of Immunohaematology","place":["Mumbai, Maharashtra, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aman","family":"Malik","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Immunology, ICMR-National Institute of Immunohaematology","place":["Mumbai, Maharashtra, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Madkaikar","sequence":"additional","affiliation":[{"name":"Department of Pediatric Immunology & Leukocyte Biology, ICMR-National Institute of Immunohaematology","place":["Mumbai, Maharashtra, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana D.","family":"Pradhan","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Immunology, ICMR-National Institute of Immunohaematology","place":["Mumbai, Maharashtra, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41392-025-02168-0","article-title":"Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics","volume":"10","author":"Dai","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-023-05346-x","article-title":"Systemic lupus erythematosus: latest insight into etiopathogenesis","volume":"43","author":"Akhil","year":"2023","journal-title":"Rheumatol Int"},{"key":"B3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s12519-019-00229-3","article-title":"Immunological pathogenesis and treatment of systemic lupus erythematosus","volume":"16","author":"Pan","year":"2020","journal-title":"World J Pediatr"},{"key":"B4","doi-asserted-by":"publisher","first-page":"16039","DOI":"10.1038\/nrdp.2016.39","article-title":"Systemic lupus erythematosus","volume":"2","author":"Kaul","year":"2016","journal-title":"Nat Rev Dis Primer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.56.7.481","article-title":"Pathogenesis of systemic lupus erythematosus","volume":"56","author":"Mok","year":"2003","journal-title":"J Clin Pathol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111327","article-title":"Cytokines as biomarkers in systemic lupus erythematosus: value for diagnosis and drug therapy","volume":"22","author":"Idborg","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.rcreu.2021.05.018","article-title":"Role of cytokines in the pathophysiology of systemic lupus erythematosus","volume":"28","author":"Rinc\u00f3n-Delgado","year":"2021","journal-title":"Rev Colomb Reumatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"432595","DOI":"10.1155\/2011\/432595","article-title":"Inflammatory cytokines in systemic lupus erythematosus","author":"Ohl","year":"2011","journal-title":"J BioMed Biotechnol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2011.0029","article-title":"The dysregulation of cytokine networks in systemic lupus erythematosus","volume":"31","author":"Apostolidis","year":"2011","journal-title":"J Interferon Cytokine Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.954706","article-title":"IFN-\u03b3, should not be ignored in SLE","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e000270","DOI":"10.1136\/lupus-2018-000270","article-title":"Interferon pathway in SLE: one key to unlocking the mystery of the disease","volume":"6","author":"R\u00f6nnblom","year":"2019","journal-title":"Lupus Sci Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/mr\/roac140","article-title":"Interferons and systemic lupus erythematosus: Pathogenesis, clinical features, and treatments in interferon-driven disease","volume":"33","author":"Tanaka","year":"2023","journal-title":"Mod Rheumatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/cells8090963","article-title":"Signaling pathways of type I and type III interferons and targeted therapies in systemic lupus erythematosus","volume":"8","author":"Chyuan","year":"2019","journal-title":"Cells"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.31138\/mjr.010324.iis399","article-title":"Interferon inhibition in SLE: from bench to bedside","volume":"35","author":"Deligeorgakis","year":"2024","journal-title":"Mediterr J Rheumatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222011286","article-title":"The pathogenesis, molecular mechanisms, and therapeutic potential of the interferon pathway in systemic lupus erythematosus and other autoimmune diseases","volume":"22","author":"Ramaswamy","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101569","article-title":"Uncoupling interferons and the interferon signature explains clinical and transcriptional subsets in SLE","volume":"5","author":"G\u00f3mez-Ba\u00f1uelos","year":"2024","journal-title":"Cell Rep Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.764062","article-title":"Type III interferons: emerging roles in autoimmunity","volume":"12","author":"Manivasagam","year":"2021","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-021-00606-1","article-title":"Interferon lambda in inflammation and autoimmune rheumatic diseases","volume":"17","author":"Goel","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13075-019-1878-y","article-title":"High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus","volume":"21","author":"Oke","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2024.100246","article-title":"Association of autoantibodies with the IFN signature and NETosis in patients with systemic lupus erythematosus","volume":"9","author":"Kaan","year":"2024","journal-title":"J Transl Autoimmun"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2025.103438","article-title":"Interferon signatures fuel B cell hyperactivity and plasmablast expansion in systemic lupus erythematosus","volume":"154","author":"van Dooren","year":"2025","journal-title":"J Autoimmun"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214819","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"78","author":"Aringer","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780350606","article-title":"Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE","volume":"35","author":"Bombardier","year":"1992","journal-title":"Arthritis Rheumatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/genes14030537","article-title":"Association of the STAT4 gene rs7574865 polymorphism with IFN-\u03b3 Levels in patients with systemic lupus erythematosus","volume":"14","author":"Esparza Guerrero","year":"2023","journal-title":"Genes"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.833636","article-title":"High interferon signature leads to increased STAT1\/3\/5 phosphorylation in PBMCs from SLE patients by single cell mass cytometry","volume":"13","author":"Yiu","year":"2022","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11030864","article-title":"Optimal selection of IFN-\u03b1-inducible genes to determine type I interferon signature improves the diagnosis of systemic lupus erythematosus","volume":"11","author":"Demers-Mathieu","year":"2023","journal-title":"Biomedicines"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1177\/0961203321990107","article-title":"Identification and stratification of systemic lupus erythematosus patients into two transcriptionally distinct clusters based on IFN-I signature","volume":"30","author":"Shobha","year":"2021","journal-title":"Lupus"},{"key":"B28","doi-asserted-by":"publisher","first-page":"E26499","DOI":"10.1097\/MD.0000000000026499","article-title":"Identification of hub genes, pathways, and related transcription factors in systemic lupus erythematosus: A preliminary bioinformatics analysis","volume":"100","author":"Wang","year":"2021","journal-title":"Med U S"},{"key":"B29","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1186\/s13104-019-4562-z","article-title":"Comparable type I interferon score determination from PAXgene and Tempus whole blood RNA collection and isolation systems","volume":"12","author":"Lamot","year":"2019","journal-title":"BMC Res Notes"},{"key":"B30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s43166-023-00215-8","article-title":"Nailfold capillaroscopy in Egyptian systemic lupus erythematosus (SLE) patients: correlation with demographic features and serum levels of IL 17A and IFNs I","volume":"50","author":"Nasser","year":"2023","journal-title":"Egypt Rheumatol Rehabil"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2021.100092","article-title":"Difference of IFI44L methylation and serum IFN-a1 level among patients with discoid and systemic lupus erythematosus and healthy individuals","volume":"4","author":"Zhang","year":"2021","journal-title":"J Transl Autoimmun"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.5114\/REUM.2020.98434","article-title":"Impact of IL-34, IFN-\u03b1 and IFN-\u03bb1 on activity of systemic lupus erythematosus in Egyptian patients","volume":"58","author":"Adel","year":"2020","journal-title":"Reumatologia"},{"key":"B33","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00296-010-1636-6","article-title":"Elevated plasma level of HMGB1 is associated with disease activity and combined alterations with IFN-\u03b1 and TNF-\u03b1 in systemic lupus erythematosus","volume":"32","author":"Ma","year":"2012","journal-title":"Rheumatol Int"},{"key":"B34","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1177\/0961203317716321","article-title":"Interferon alpha gene expression and serum level association with low vitamin D levels in Egyptian female patients with systemic lupus erythematosus","volume":"27","author":"Abdel Galil","year":"2018","journal-title":"Lupus"},{"key":"B35","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.cyto.2010.02.017","article-title":"Interferon-alpha and interleukin-6 in SLE serum induce the differentiation and maturation of dendritic cells derived from CD34+ hematopoietic precursor cells","volume":"50","author":"Zhang","year":"2010","journal-title":"Cytokine"},{"key":"B36","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1186\/ar2382","article-title":"Dysfunctional interferon-\u03b1 production by peripheral plasmacytoid dendritic cells upon Toll-like receptor-9 stimulation in patients with systemic lupus erythematosus","volume":"10","author":"Kwok","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"B37","doi-asserted-by":"publisher","first-page":"23475","DOI":"10.1038\/s41598-024-72564-z","article-title":"Cytokine profiles and their correlation with clinical and blood parameters in rheumatoid arthritis and systemic lupus erythematosus","volume":"14","author":"Duarte-Delgado","year":"2024","journal-title":"Sci Rep"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2023.109239","article-title":"Interrelation of T cell cytokines and autoantibodies in systemic lupus erythematosus: A cross-sectional study","volume":"247","author":"Alduraibi","year":"2023","journal-title":"Clin Immunol Orlando Fla"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.21608\/smj.2022.131134.1314","article-title":"Interleukin-4, and interferon-gamma roles as biomarkers in Systemic Lupus Erythematosus patients","volume":"26","author":"Mostafa","year":"2022","journal-title":"Sohag Med J"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jksus.2022.102007","article-title":"Cytokines and autoantibodies profile during systemic lupus erythematosus and psoriasis diseases in Egypt","volume":"34","author":"Farid","year":"2022","journal-title":"J King Saud Univ - Sci"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.4103\/0366-6999.235110","article-title":"Increased macroautophagy in interferon-gamma-producing T cells from patients with newly diagnosed systemic lupus erythematosus","volume":"131","author":"Luo","year":"2018","journal-title":"Chin Med J (Engl)"},{"key":"B42","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s13075-018-1683-z","article-title":"Interferon-\u03bb3\/4 genetic variants and interferon-\u03bb3 serum levels are biomarkers of lupus nephritis and disease activity in Taiwanese","volume":"20","author":"Chen","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000000581","article-title":"Type III interferons in systemic lupus erythematosus: association between interferon \u03bb3, disease activity, and anti-ro\/SSA antibodies","volume":"23","author":"Amezcua-Guerra","year":"2017","journal-title":"J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"key":"B44","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s13075-017-1344-7","article-title":"IFN-\u03bb1 with Th17 axis cytokines and IFN-\u03b1 define different subsets in systemic lupus erythematosus (SLE)","volume":"19","author":"Oke","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4927530","article-title":"Serum cytokines th1, th2, and th17 expression profiling in active lupus nephritis-IV: from a southern Chinese Han population","volume":"4927530","author":"Sigdel","year":"2016","journal-title":"Mediators Inflamm"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e000170","DOI":"10.1136\/lupus-2016-000170","article-title":"Interferon (IFN)-\u03bb is a potential mediator in lupus nephritis","volume":"3","author":"Zickert","year":"2016","journal-title":"Lupus Sci Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-014-3020-4","article-title":"Increased serum APRIL differentially correlates with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients","volume":"34","author":"Boghdadi","year":"2014","journal-title":"Rheumatol Int"},{"key":"B48","doi-asserted-by":"publisher","first-page":"R88","DOI":"10.1186\/ar3363","article-title":"Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity","volume":"13","author":"Wu","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"B49","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13075-021-02414-0","article-title":"The baseline interferon signature predicts disease severity over the subsequent 5 years in systemic lupus erythematosus","volume":"23","author":"Mai","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100291","article-title":"Adults with systemic lupus exhibit distinct molecular phenotypes in a cross-sectional study","volume":"20","author":"Guthridge","year":"2020","journal-title":"EClinicalMedicine"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1177\/0961203315584811","article-title":"Vitamin D levels and cytokine profiles in patients with systemic lupus erythematosus","volume":"24","author":"Schneider","year":"2015","journal-title":"Lupus"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.647487","article-title":"Interferon lambda 3\/4 (IFN\u03bb3\/4) rs12979860 polymorphisms is not associated with susceptibility to systemic lupus erythematosus, although it regulates OASL expression in patients with SLE","volume":"12","author":"Ju\u00e1rez-Vicu\u00f1a","year":"2021","journal-title":"Front Genet"},{"key":"B53","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.1038\/s41598-017-04186-7","article-title":"IFN-\u03bb4 potently blocks IFN-\u03b1 signalling by ISG15 and USP18 in hepatitis C virus infection","volume":"7","author":"Sung","year":"2017","journal-title":"Sci Rep"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix593","article-title":"Genetic variation at IFNL4 influences extrahepatic interferon-stimulated gene expression in chronic HCV patients","volume":"217","author":"Rosenberg","year":"2018","journal-title":"J Infect Dis"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2100339","article-title":"B cell activation and plasma cell differentiation are promoted by IFN-k in systemic lupus erythematosus","volume":"207","author":"Barnas","year":"2021","journal-title":"J Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1757895\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T09:15:54Z","timestamp":1771924554000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1757895\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":55,"alternative-id":["10.3389\/fimmu.2026.1757895"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1757895","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]},"article-number":"1757895"}}